Literature DB >> 2902017

A Taqi RFLP of the human TGF alpha gene is significantly associated with cutaneous malignant melanoma.

N Hayward1, D Nancarrow, K Ellem, P Parsons, C Kidson.   

Abstract

A TaqI restriction fragment length polymorphism (RFLP) of the human transforming growth factor alpha (hTGF alpha) locus was analyzed in DNA from 63 normal individuals, 34 malignant melanoma (MM) cell lines, and 18 melanoma biopsy specimens. The frequency of a 2.7-kb allele (0.18) in MM cell lines was significantly higher (p less than 0.01) than in lymphoblastoid cell lines (LCLs) derived from unaffected controls (0.05). The frequency (0.14) in MM biopsies was similar to that in MM cell lines although, owing to the small numbers investigated, it was not significantly higher than in controls. In the case of 5 MM patients who were constitutionally heterozygous for alleles at the TGF alpha locus, no apparent losses of heterozygosity were observed in the corresponding tumour DNA. Thus, the constitutional presence of the 2.7-kb allele may be a risk factor for melanoma.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2902017     DOI: 10.1002/ijc.2910420415

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  3 in total

1.  Further evidence for an association between genetic variation in transforming growth factor alpha and cleft lip and palate.

Authors:  G Chenevix-Trench; K Jones; A Green; N Martin
Journal:  Am J Hum Genet       Date:  1991-05       Impact factor: 11.025

2.  Transforming growth factor-alpha: characterization of the BamHI, RsaI, and TaqI polymorphic regions.

Authors:  J F Qian; J Feingold; C Stoll; E May
Journal:  Am J Hum Genet       Date:  1993-07       Impact factor: 11.025

3.  Cleft lip with or without cleft palate: associations with transforming growth factor alpha and retinoic acid receptor loci.

Authors:  G Chenevix-Trench; K Jones; A C Green; D L Duffy; N G Martin
Journal:  Am J Hum Genet       Date:  1992-12       Impact factor: 11.025

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.